These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2653244)

  • 21. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
    Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
    J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
    J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.
    Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B
    Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica.
    Reitsema RD; Hesselink BC; Abdulahad WH; van der Geest KSM; Brouwer E; Heeringa P; van Sleen Y
    Front Immunol; 2023; 14():1201575. PubMed ID: 37600779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
    Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
    Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis.
    Martinez-Taboada VM; Goronzy JJ; Weyand CM
    Clin Immunol Immunopathol; 1996 Jun; 79(3):263-70. PubMed ID: 8635285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS; Abdulahad WH; Chalan P; Rutgers A; Horst G; Huitema MG; Roffel MP; Roozendaal C; Kluin PM; Bos NA; Boots AM; Brouwer E
    Arthritis Rheumatol; 2014 Jul; 66(7):1927-38. PubMed ID: 24623536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
    Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency.
    Wirsum C; Glaser C; Gutenberger S; Keller B; Unger S; Voll RE; Vach W; Ness T; Warnatz K
    J Clin Immunol; 2016 May; 36(4):406-12. PubMed ID: 26980224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy.
    Boiardi L; Salvarani C; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
    Br J Rheumatol; 1996 Jul; 35(7):642-8. PubMed ID: 8670597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of a normal erythrocyte sedimentation rate in patients with active, untreated arteritis temporalis and polymyalgia rheumatica: comment on the article by Helfgott and Kieval.
    Olsson AT; Elling H; Elling P
    Arthritis Rheum; 1997 Jan; 40(1):191-3. PubMed ID: 9008618
    [No Abstract]   [Full Text] [Related]  

  • 32. Laboratory investigations including liver in polymyalgia rheumatica/giant cell arteritis.
    Kyle V
    Baillieres Clin Rheumatol; 1991 Dec; 5(3):475-84. PubMed ID: 1807822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica.
    Große K; Schmidt RE; Witte T; Baerlecken NT
    Scand J Rheumatol; 2013; 42(3):215-9. PubMed ID: 23682607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
    Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
    Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
    Kyle V; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study.
    Schmidt J; Duhaut P; Bourgeois AM; Salle V; Smail A; Chatelain D; Betsou F; Mazière JC; Ducroix JP;
    Rheumatology (Oxford); 2009 Feb; 48(2):158-9. PubMed ID: 19098302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral blood lymphocyte subsets in polymyalgia rheumatica.
    Uddhammar A; Roos G; Näsman B; Dahlqvist SR
    Clin Rheumatol; 1995 Jan; 14(1):62-7. PubMed ID: 7743746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immunity in polymyalgia rheumatica and giant cell arteritis: lack of response to muscle or artery homogenates.
    Papaioannou CC; Hunder GG; McDuffie FC
    Arthritis Rheum; 1979 Jul; 22(7):740-5. PubMed ID: 454501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
    Dababneh A; Gonzalez-Gay MA; Garcia-Porrua C; Hajeer A; Thomson W; Ollier W
    J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
    González-Gay MA; Amoli MM; Garcia-Porrua C; Ollier WE
    Semin Arthritis Rheum; 2003 Aug; 33(1):38-48. PubMed ID: 12920695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.